Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 12, No 5 (2016) Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis Abstract  similar documents
M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov
"... . Negative correlation between the statins receiving and serum endothelin level was found in men (r=-0.11; p ..."
 
Vol 5, No 6 (2009) STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? Abstract  similar documents
I. N. Grigorieva, Y. M. Pozdnyakov
"... ), non-alcoholic steatohepatitis (NASH) and hypercholesterolemia (HCE) with statins and ursodeoxycholic ..."
 
Vol 9, No 5 (2013) CLINICAL IMPORTANCE OF ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. N. Kushnarenko, A. V. Govorin
"... artery by ultrasonic Doppler examination. The level of nitrite-nitrate and endothelin-1 in blood serum ..."
 
Vol 11, No 5 (2015) Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation Abstract  similar documents
E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
"... arthritis (RA) is accompanied by deterioration of blood lipid profile. Aim. To study changes in serum lipid ..."
 
Vol 9, No 4 (2013) STATINS AND THE RISK OF DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina
"... of serum low density lipoprotein cholesterol level by 25-50% from the baseline. Statins may increase ..."
 
Vol 4, No 4 (2008) ENDOTHELIAL DYSFUNCTION IN ISCHEMIC HEART DISEASE Abstract  similar documents
N. E. Zakirova, R. G. Oganov, A. N. Zakirova, M. P. Plotnikova, G. M. Salakhova
"... ) of brachial artery. Vasoconstrictive function was assessed by the level of endothelin (ET-1). Endothelial ..."
 
Vol 8, No 3 (2012) STATINS AND MYOPATHY: MOLECULAR MECHANISMS Abstract  similar documents
O. M. Drapkina, E. M. Chernova, O. N. Korneeva
"... The safety of statin therapy is considered. In particular the reasons of a complication ..."
 
Vol 9, No 2 (2013) STATIN SAFETY REVISITED DATA Abstract  similar documents
O. M. Drapkina
"... Questions of statins use in liver diseases are discussed. Data from clinical studies on statins ..."
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..."
 
Vol 13, No 2 (2017) ENDOTHELIAL DYSFUNCTIONS AND THEIR CORRECTION IN WOMEN WITH EARLY POSTMENOPAUSE Abstract  similar documents
S. N. Tolstov, I. A. Salov, A. P. Rebrov
"... was assessed by reactive hyperemia. Endothelial dysfunction (ED) markers - plasma levels of endothelin-1 (ET-1 ..."
 
Vol 9, No 1 (2013) MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina, B. B. Gegenava
"... , атеросклероз, фиброз, диабетическая кардиомиопатия, статины, бета-блокаторы, ингибиторы АПФ, тиазолидиндионы ..."
 
Vol 10, No 5 (2014) STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE Abstract  similar documents
L. N. Malay
"... Statins, the most common drugs for reduction in lipid levels, are “strategic” medicinal products ..."
 
Vol 7, No 2 (2011) LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE Abstract  similar documents
A. V. Susekov, N. V. Khokhlova
"... The evidences for statin use in cardiology are presented. Especially hypolipidemic efficacy ..."
 
Vol 11, No 1 (2015) MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT Abstract  similar documents
O. M. Drapkina, E. M. Chernova
"... Statins are lipid-lowering drugs with proven efficacy that reduce cardiovascular risk and are well ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... in patients with CVD risk factors, of course, are statins. The results of multi-center studies showing ..."
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
"... The evidence base of statin therapy in primary and secondary prevention of ischemic stroke ..."
 
Vol 8, No 4 (2012) EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS Abstract  similar documents
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze
"... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..."
 
Vol 9, No 3 (2013) STATINS AND RISK OF INFECTIOUS DISEASES Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... Besides hypolipidemic effect statins demonstrate some not-lipid (pleotropic) ones. Special ..."
 
Vol 5, No 6 (2009) STATIN GENERICS: EFFICACY AND SAFETY RATIO Abstract  similar documents
V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova
"... Statin usage for primary and secondary prevention of cardiovascular diseases is focused. Rational ..."
 
Vol 12, No 5 (2016) Statins in Secondary Prevention of Atrial Fibrillation Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... group II (n=32) did not take statins. The duration of follow-up was 4 years. The evolution of the AF ..."
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
"... it possible to use statin therapy in patients with concomitant liver diseases only when serum transaminase ..."
 
Vol 5, No 3 (2009) CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva
"... intake and not appropriate BP self-monitoring. Low frequency of statins therapy and non-targeted ..."
 
Vol 2, No 4 (2006) POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN Abstract  similar documents
I. V. Logacheva, E. N. Shustova, E. V. Kulinich
"... (ACE inhibitor and statin), not only have antihypertensive and hypolipidemic action, but also reduce ..."
 
Vol 10, No 6 (2014) DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) Abstract  similar documents
A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov
"... hypercholesterolemia were classified as patients at high or very high cardiovascular risk, but statins were recommended ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... The main indications to statins and principles of statin usage on the basis of International ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... levels of serum transaminases are detected. To expand the use of statins in these patients, a scheme ..."
 
Vol 7, No 3 (2011) REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427 Abstract  similar documents
N. V. Perova
"... Comparative dose-dependent ability of different statins to lower serum low-density lipoproteins ..."
 
Vol 10, No 3 (2014) THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW Abstract  similar documents
D. A. Napalkov
"... Various aspects of the safety of statins in clinical practice are discussed: hepatotoxicity ..."
 
Vol 3, No 1 (2007) MICROCIRCULATORY ISCHEMIA AND STATINS: LESSONS OF INTERVENTION CARDIOLOGY Abstract  similar documents
An. A. Alexandrov, I. I. Tchukaeva
"... . Therapy by statins can be beneficial for patients with microcirculatory ischemia. ..."
 
Vol 11, No 6 (2015) Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon? Abstract  similar documents
I. A. Latfullin, L. F. Galiullina, I. Z. Rakhmatullin, V. V. Klochkov, A. V. Aganov
"... A hypothesis that possible pleiotropic features of different statins could be explained ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... Background. Effects of statins on cardiovascular end points are well-known. To study the impact ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... for statins use. Material and methods. Patients (n=262, age 60.1±8.9 years) took statins for secondary ..."
 
Vol 8, No 5 (2012) LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS Abstract  similar documents
A. N. Meshkov
"... of the study of rosuvastatin therapy efficacy , in comparison with other statins, received in controlled ..."
 
Vol 2, No 2 (2006) PROBLEM OF TREATMENT WITH STATINS IN RUSSIA: WILL GENERICS HELP? Abstract  similar documents
S. Y. Martsevich
"... The article underlines necessity of statins treatment for patients with high risk of cardio ..."
 
Vol 14, No 4 (2018) Statin Therapy and Cognitive Impairment: Benefit or Harm? Abstract  similar documents
O. D. Ostroumova, E. V. Chikh, E. V. Rebrova, A. Yu. Ryazanova
"... Statins are now widely used drugs for the treatment of dyslipidemia, effective drugs for lowering ..."
 
Vol 11, No 4 (2015) TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE Abstract  similar documents
V. A. Korneva, T. Yu. Kuznetsova, E. S. Karpova, K. I. Rupasova
"... cholesterol >9 mmol/l) the frequency of statins prescription in 2009-2012 was 70%. In 28.9% of the patients ..."
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... группы статинов [2]. Статины являются наиболее перспективным классом гиполипидемических средств ..."
 
Vol 4, No 4 (2008) LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Abstract  similar documents
A. S. Kerimkulova, A. M. Noruzbaeva, O. S. Lunegova, B. Z. Imanov, M. A. Pavlenko, A. E. Mirrahimov, I. JU. Gottfried, E. M. Mirrahimov
"... функцию ЛЖ. Ключевые слова: статины, толщина комплекса интима-медиа, ремоделирование, фракция выброса ..."
 
Vol 10, No 4 (2014) STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN Abstract  similar documents
N. G. Gogolashvili
"... - пользования статинов перед выполнением ЧКВ [3-6]. Од- ним из наиболее изученных препаратов этого класса в дан ..."
 
Vol 1, No 3 (2005) RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS Abstract  similar documents
D. A. Anichkov, N. A. Shostak
"... . The perspectives of treatments with statins in RA are given. Results of clinical trials on statin effects ..."
 
Vol 10, No 5 (2014) STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... been focused on statins use. Evidence base of this drugs class use in the perioperative period serves ..."
 
Vol 9, No 6 (2013) APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY Abstract  similar documents
D. A. Sychev, G. N. Shuev, A. B. Prokofiev
"... polipeptide) in the development of statin induced myopathy is considered. Possible tactics of statin dose ..."
 
Vol 14, No 6 (2018) Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues Abstract  PDF (Eng)  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan
"... on a low number of patients taking statins, and even less – reaching recommended target cholesterol levels ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... lipid-lowering therapy and can be considered as a predictor of resistance to statins.  ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... using Propensity Score Matching. Material and methods. 262 patients aged 60.1±8.9 years, taking statins ..."
 
Vol 1, No 2 (2005) STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY Abstract  similar documents
Y. A. Karpov
"... , aswell as problems of statin treatment safety. The choice of the drug must be based on clinical research ..."
 
Vol 6, No 6 (2010) COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE Abstract  similar documents
S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova
"... function, ability to reduce the blood level of C-reactive protein are important in the statins mode ..."
 
Vol 6, No 4 (2010) EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK Abstract  similar documents
N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya
"... Current views on the efficacy criteria of hyperlipidaemia treatment with statins are considered ..."
 
Vol 11, No 3 (2015) ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta
"... was significantly above the target and varied from 5.82 to 6.10 mmol/L. At that, statins had not been prescribed ..."
 
Vol 9, No 2 (2013) MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina
"... in the main group compared to the control (p<0.05). Statins were constantly taken by 34% of patients ..."
 
Vol 11, No 5 (2015) Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis Abstract  similar documents
N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov
"... Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients ..."
 
Vol 5, No 2 (2009) OBSERVATIONAL TRAILS IN LIPIDOLOGY Abstract  similar documents
S. A. Shalnova
"... and observational trails are presented. The trail data on statins efficacy and safety are held up as a model. ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
 
Vol 13, No 4 (2017) HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? Abstract  similar documents
I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova
"... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..."
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
"... , Post-CABG, TNT) and meta-analyzes on the role of statins, prescribed before and after coronary artery ..."
 
Vol 13, No 3 (2017) ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING Abstract  similar documents
A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya
"... metabolism and biochemical safety of statin use were analyzed. The duration of observation of results ..."
 
Vol 8, No 6 (2012) ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE Abstract  similar documents
A. I. Chesnikova, V. A. Safronenko, A. V. Hripun
"... of myocardial infarction (MI) depending on the statin therapy compliance. Material and methods. Patients (n=31 ..."
 
Vol 7, No 3 (2011) STROKE PREVENTION IN INTERNIST PRACTICE Abstract  similar documents
D. A. Napalkov, A. V. Zhilenko
"... guidelines. Modern pharmacotherapy includes antiaggregants or anticoagulants, statins, and antihypertensive ..."
 
Vol 4, No 3 (2008) DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY Abstract  similar documents
E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin
"... пароксизмальной формой ФП. Ключевые слова: вариабельность ритма сердца, ишемическая болезнь сердца, статины ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... .39%, statins – 69.45%). When assessing prescribed doses of drugs, an increase in a number of their higher doses ..."
 
Vol 13, No 2 (2017) STATINS AND THEIR INTERACTION WITH MODEL CELL MEMBRANES ACCORDING TO THE DATA OF NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY Abstract  similar documents
I. A. Latfullin, L. F. Galiullina, G. S. Musabirova, O. V. Aganova, Z. F. Kim, A. V. Aganov, V. V. Klochkov
"... interatomic distances between the atoms of statins and micelles. Material and methods. Nuclear magnetic ..."
 
Vol 9, No 3 (2013) INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina
"... Aim. To assess the risk factors of statin-associated muscle damage in patient with ischemic heart ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... to use statins in patients with cardiovascular diseases and concomitant chronic liver diseases. Analysis ..."
 
Vol 12, No 1 (2016) Pharmacotherapy of pulmonary hypertension (according to the 2015 ESC/EAS Guidelines for the diagnosis and treatment of pulmonary hypertension) Abstract  PDF (Eng)  similar documents
E. L. Trisvetova, S. V. Gubkin
"... , specific therapy with calcium channel blockers, prostacyclin analogues, endothelin receptor antagonists ..."
 
Vol 9, No 4 (2013) REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy
"... Aim. To analyze tactics of statins use in patients with high cardiovascular risk on the base ..."
 
Vol 14, No 3 (2018) HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE Abstract  similar documents
O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta
"... . The issues of lipid-lowering therapy with statins in the aspect of stroke prevention are discussed ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... антитромбоцитарных свойств статинов, их связь со стимуляцией продукции оксида азота, мощного эндогенного ..."
 
Vol 13, No 6 (2017) SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS Abstract  similar documents
I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova
"... lipoproteins in men and women with coronary atherosclerosis treated with statins depending on low density ..."
 
Vol 11, No 2 (2015) HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... Aim. To evaluate the frequency of prescription, efficacy and patients adherence to statin therapy ..."
 
Vol 9, No 5 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... hospital. In specialized hospital the rate of aspirin use increased by 30%, statins - by 80%, beta-blockers ..."
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... , статины. Рациональная фармакотерапия в кардиологии 2015;11(5):504-509 Three-year dynamics and unsolved ..."
 
Vol 2, No 1 (2006) DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT Abstract  similar documents
O. V. Andropova, V. N. Anokhin
"... воспаления, ингибиторы ангиотензинпревращающего фермента, статины РФК 2006; 1: 31-36 Degenerative aortic ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... .3%, statins – up to 45.6%. Despite of no changes registered in prescription rate of the ACE inhibitors, marked ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... Aim. To study adherence to treatment with generic statins prescribed to patients with high and very ..."
 
Vol 15, No 1 (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength Abstract  similar documents
I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova
"... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..."
 
Vol 10, No 3 (2014) ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko, M. N. Titarenko, O. R. Pastuchova
"... of endothelin (ET-1) in serum and urine decreased by 26.1% and by 76.1%, respectively, p<0.05. A statistically ..."
 
Vol 7, No 1 (2011) EXPERT CONCLUSION OF THE SOCIETY OF CARDIOLOGY OF THE RUSSIAN FEDERATION, RUSSIAN NATIONAL SOCIETY OF ATHEROSCLEROSIS, RUSSIAN SOCIETY OF CARDIOSOMATIC REHABILITATION AND SECONDARY PREVENTION ON STATIN THERAPY OPTIMIZATION IN CLINICAL PRACTICE  similar documents
"... событий более чем на 1/3. Существующие сего- дня в арсенале врачей статины (ловастатин, праваста- тин ..."
 
Vol 12, No 2 (2016) LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta
"... гиполипидемический эффект препарата. Ключевые слова: дислипидемия, общий холестерин, реальная практика, статины ..."
 
Vol 8, No 3 (2012) EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE Abstract  similar documents
T. N. Khaybullin, E. Yu. Kravtsova, G. A. Martynova
"... of neutral and alkaline aldehyde and ketone derivates in blood serum proteins were maximal in all wave ..."
 
Vol 14, No 2 (2018) MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. F. Zadvorev, A. A. Yakovlev, A. S. Pushkin, S. A. Rukavishnikova, A. E. Filippov, A. G. Obrezan
"... Background. Monitoring of serum digoxin concentration (SDC) is one of the approaches ..."
 
Vol 10, No 5 (2014) THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE Abstract  similar documents
N. E. Zakirova, A. N. Zakirova
"... by endothelium-dependent vasodilatation (EDVD) and levels of endothelin-1 (ET-1) and adhesion molecules. Results ..."
 
Vol 2, No 4 (2006) EFFECTS OF ENALAPRIL ON ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
L. I. Katelnizkaya, L. A. Chaischeva
"... monitoring were made, the thickness of intima-media complex of carotid artery and the level of endothelin-1 ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... vasoconstrictor endothelin. In the metabolic syndrome, in which there is a significant risk of developing renal ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipoprotein ..."
 
Vol 14, No 3 (2018) OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS Abstract  similar documents
S. F. Zadvorev, A. A. Yakovlev, A. S. Pushkin, S. A. Rukavishnikova, A. E. Filippov, A. G. Obrezan
"... or persistent atrial fibrillation (AF). Monitoring of serum digoxin concentration (SDC) seems to be perspective ..."
 
Vol 5, No 3 (2009) FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY Abstract  similar documents
O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova
"... daily). Basic therapy included anticoagulants, antiplatelets, beta-blockers, nitrates and statins ..."
 
Vol 7, No 3 (2011) VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY Abstract  similar documents
E. P. Trukhacheva, M. V. Ezhov
"... Statin intake is a standard in the treatment of patients with atherosclerosis nowadays ..."
 
Vol 12, No 3 (2016) EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY Abstract  PDF (Eng)  similar documents
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz
"... and polypharmacy that increase the risk of adverse reactions due to the use of both statins and their drug-drug ..."
 
Vol 6, No 4 (2010) CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE Abstract  similar documents
O. I. Afanasieva, M. V. Ezhov, M. I. Afanasieva, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky
"... vascular area in 18-50% of patients. High serum level of lipoprotein(a) [Lp(a)] is an independent risk ..."
 
Vol 14, No 1 (2018) EVALUATION OF LEPTIN SERUM LEVELS IN PATIENTS WITH METABOLIC SYNDROME AND LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY Abstract  PDF (Eng)  similar documents
O. M. Drapkina, R. N. Shepel, T. A. Deeva
"... Aim. To study serum level of leptin in patients with the metabolic syndrome (MS), including ..."
 
Vol 8, No 4 (2012) UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION Abstract  similar documents
E. A. Protasova, N. V. Furman, O. V. Reshet'ko
"... Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 ..."
 
Vol 9, No 2 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... of cardiovascular complications (antiplatelets, β-blockers, ACE inhibitors, statins) were not often prescribed ..."
 
Vol 15, No 3 (2019) Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus Abstract  similar documents
Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis
"... -selectin, endothelin, transforming growth factor (TGF-β1), endothelial growth factor A. Results. In compare ..."
 
Vol 10, No 5 (2014) RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME Abstract  similar documents
N. V. Perova, V. A. Metelskaya
"... of dyslipidemia correction. The use of statins as lipid-lowering therapy in patients with acute coronary syndrome ..."
 
Vol 3, No 4 (2007) EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE Abstract  similar documents
A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova
"... peroxidation (LP) products, cytokines, endothelin-1 (ET-1), intercellular adhesive molecule (VCAM-1) were ..."
 
Vol 8, No 6 (2012) THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS Abstract  similar documents
S. Yu. Martsevich, M. L. Gynzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. U. Drozdova, E. V. Daniels, A. V. Fokina
"... -blockers, ACE inhibitors, statins), at that ACE inhibitors were prescribed more often than the others. Use ..."
 
Vol 8, No 1 (2012) GENDER DISTINCTIONS OF MICROALBUMINURIA AND ITS RELATION TO INTRARENAL HEMODYNAMIC AND LEPTIN LEVEL IN ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, J. N. Rodionova
"... to intrarenal hemodynamic, glomerular filtration rate (GFR), and leptin serum level in essential hypertension ..."
 
Vol 14, No 3 (2018) THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova
"... schemes and the preferred doses of statins and antiplatelet agents depending on the localization ..."
 
Vol 8, No 1 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... , renalase, endothelin receptors, (pro)renin receptors, vaccine against RAAS components. Development of novel ..."
 
Vol 8, No 5 (2012) THE LIS STUDY (LYUBERTSY STUDY OF MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION). EVALUATION OF THE PHARMACOTHERAPY. PART 1. TREATMENT OF PATIENTS BEFORE MYOCARDIAL INFARCTION AND ITS INFLUENCE ON HOSPITAL MORTALITY RATE Abstract  similar documents
S. Y. Marcevich, M. L. Ginzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. Y. Drozdova, E. V. Danijel's, A. V. Fokina
"... -blockers, 35.3% — ACE inhibitors, 15.7% — antiplatelet drugs, 1.9% — statins. Reduction in the hospital ..."
 
1 - 100 of 551 Items 1 2 3 4 5 6 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)